On November 20, 2021, Hengrui Pharmaceuticals Co. announced that it decided to change capitalization point of R&D
Fantastic news! We've Found the answer you've been seeking!
Question:
On November 20, 2021, Hengrui Pharmaceuticals Co. announced that it decided to change capitalization point of R&D expenditure to make the measurement of R&D expenditure more in line with the company's actual situation.
Required:
(1) Describe the financial performance of Hengrui Co..
(2) What's the type of this change? And what's the method for the change?
(3) What are expected effects on the financial statements of Hengrui Co.. by this change?
(4) What are reasons for this change for Hengrui Co..
(5) What are usefulness and limitation of EPS?
Related Book For
Data Analysis and Decision Making
ISBN: 978-0538476126
4th edition
Authors: Christian Albright, Wayne Winston, Christopher Zappe
Posted Date: